Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zimmerman

Showing results (861-870 of 915) with videos related to

Pageof 92
Sort By:
Journal of Medicinal Chemistry|December 19, 1998
Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidineJ B Thomas, M J Fall, J B Cooper, et al.
Journal of Medicinal Chemistry|July 21, 1998
Synthesis and evaluation of a series of novel 2-[(4-chlorophenoxy)methyl]benzimidazoles as selective neuropeptide Y Y1 receptor antagonistsH Zarrinmayeh, A M Nunes, P L Ornstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2011
Serologically confirmed household transmission of 2009 pandemic influenza A (H1N1) virus during the first pandemic wave--New York City, April-May 2009Michael L Jackson, Anne M France, Kathy Hancock, et al.
Drugs & Aging|October 19, 2023
Low-Income Older Adults' Vulnerability to Anticholinergic Medication-Associated FrailtyLana Sargent, Kristin M Zimmerman, Almutairi Mohammed, et al.
Journal of Medicinal Chemistry|June 27, 2003
Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonistJames B Thomas, Robert N Atkinson, N Ariane Vinson, et al.
ACS Catalysis|August 9, 2021
Mechanistic Study of Isotactic Poly(propylene oxide) Synthesis using a Tethered Bimetallic Chromium Salen CatalystBryce M Lipinski, Katherine L Walker, Naomi E Clayman, et al.
Clinical and Vaccine Immunology : CVI|January 18, 2013
Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York city in 2009Jennifer S Rota, Jennifer B Rosen, Margaret K Doll, et al.
Journal of Medicinal Chemistry|May 3, 2002
Design and synthesis of a novel series of 1,2-disubstituted cyclopentanes as small, potent potentiators of 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid (AMPA) receptorsTimothy A Shepherd, James A Aikins, David Bleakman, et al.
Journal of Medicinal Chemistry|July 26, 2002
Discovery of an opioid kappa receptor selective pure antagonist from a library of N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphansJames B Thomas, Robert N Atkinson, Nivedita Namdev, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 6, 2003
LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's diseaseTracey K Murray, Katherine Whalley, Christine S Robinson, et al.
Pageof 92

Showing results (861-870 of 915) with videos related to

Sort By:
Pageof 92
Journal of Medicinal Chemistry|December 19, 1998
Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidineJ B Thomas, M J Fall, J B Cooper, et al.
Journal of Medicinal Chemistry|July 21, 1998
Synthesis and evaluation of a series of novel 2-[(4-chlorophenoxy)methyl]benzimidazoles as selective neuropeptide Y Y1 receptor antagonistsH Zarrinmayeh, A M Nunes, P L Ornstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2011
Serologically confirmed household transmission of 2009 pandemic influenza A (H1N1) virus during the first pandemic wave--New York City, April-May 2009Michael L Jackson, Anne M France, Kathy Hancock, et al.
Drugs & Aging|October 19, 2023
Low-Income Older Adults' Vulnerability to Anticholinergic Medication-Associated FrailtyLana Sargent, Kristin M Zimmerman, Almutairi Mohammed, et al.
Journal of Medicinal Chemistry|June 27, 2003
Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonistJames B Thomas, Robert N Atkinson, N Ariane Vinson, et al.
ACS Catalysis|August 9, 2021
Mechanistic Study of Isotactic Poly(propylene oxide) Synthesis using a Tethered Bimetallic Chromium Salen CatalystBryce M Lipinski, Katherine L Walker, Naomi E Clayman, et al.
Clinical and Vaccine Immunology : CVI|January 18, 2013
Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York city in 2009Jennifer S Rota, Jennifer B Rosen, Margaret K Doll, et al.
Journal of Medicinal Chemistry|May 3, 2002
Design and synthesis of a novel series of 1,2-disubstituted cyclopentanes as small, potent potentiators of 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid (AMPA) receptorsTimothy A Shepherd, James A Aikins, David Bleakman, et al.
Journal of Medicinal Chemistry|July 26, 2002
Discovery of an opioid kappa receptor selective pure antagonist from a library of N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphansJames B Thomas, Robert N Atkinson, Nivedita Namdev, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 6, 2003
LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's diseaseTracey K Murray, Katherine Whalley, Christine S Robinson, et al.
Pageof 92